Ignite Creation Date:
2024-05-05 @ 5:31 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00476723
Status:
COMPLETED
Last Update Posted:
2010-06-07
First Post:
2006-11-15
Brief Title:
HBV-specific T-cell Immunity in Individuals With HIVHBV Co-infection
Sponsor:
The HIV Netherlands Australia Thailand Research Collaboration
Organization:
The HIV Netherlands Australia Thailand Research Collaboration
Study Overview
Official Title:
Generation of HBV-specific T-cell Immunity in Individuals With HIVHBV Co-infection Receiving HBV-active Antiretroviral Therapy
Status:
COMPLETED
Status Verified Date:
2010-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The trial will randomise HIVHBV co-infected individuals to different HBV-active antiretroviral therapy treatment regimens
Detailed Description:
Longitudinal study of circulating and intra-hepatic HBV-specific T-cell immunity in the setting of a randomised controlled international multi-centre outpatient trial The trial will randomise HIVHBV co-infected individuals to different HBV-active antiretroviral therapy treatment regimens
Study population Patients with HIVHBV co-infection who are naive to HIVHBV therapy have detectable HBV viremia and are willing to start antiretroviral therapy
Study population Patients with HIVHBV co-infection who are naive to HIVHBV therapy have detectable HBV viremia and are willing to start antiretroviral therapy
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None